Log in
Enquire now
‌

Rochal Industries, LLC SBIR Phase I Award, September 2018

A SBIR Phase I contract was awarded to Rochal Industries, LLC in September, 2018 for $222,276.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

OverviewStructured DataIssuesContributors

Contents

sbir.gov/node/1571355
Is a
SBIR/STTR Awards
SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient
‌
Rochal Industries, LLC
0
Government Agency
0
Government Branch
National Institutes of Health
National Institutes of Health
0
Award Type
SBIR0
Contract Number (US Government)
1R43AR074783-010
Award Phase
Phase I0
Award Amount (USD)
222,2760
Date Awarded
September 12, 2018
0
End Date
February 28, 2019
0
Abstract

SUMMARY Chronic wounds are a significant health problemcases of which are increasing due to rising numbers of diabetic patientsan upsurge in obesityan increase in cardiovascular diseaseand an aging of the population in the USAEuropeJapanand ChinaClinical characteristics of chronic wounds are that they are hypoxichave low oxygen levelswhich hinders the healing processand are moderately to highly exudatingWhile many types of dressings for chronic wounds are indeed availablethe transformative dressing of this proposal addresses a poorly understood key propertydriving oxygen into a water filledexudatingwound bedsuch as that found with most chronic woundsWater covering the wound bed has low absorption of dissolved oxygen andhencepoor oxygen transport capabilityWater is the rate limiting step for surface oxygen to penetrate hypoxic tissueThe research of this proposal is being designed to overcome this limitationThe overall goal of this proposal is to commercialize a product that can profoundly improve the wound healing process by transporting oxygen to hypoxic wound tissue while simultaneously removing wound exudatewhich typically is rich in degradative proteases and microbial burdenthat also hinder wound healingThe specific aims of this proposal include synthesizing oxygen transporting polymersmechanically incorporating water absorbing polymersand testing the resulting materialsRochalandapos s marketing and sales subsidiaryAtteris Healthcarewill launch the productif successfulresulting from this researchThe Atteris and Rochal teams have determined a wound care market need for a product such as of this proposaland are approaching the science in a unique and soundalthough riskymannerto provide ultimately a more conducive environment for wound healing for hypoxic wounds that are nonhealing or difficult to heal NARRATIVE A unique material is proposed that could have great utility in healing of hypoxic chronic woundssuch as those found on the elderly or those suffering from diabetesatherosclerosisor obesityThis proposed technology could be a forerunner of a new class of materials for delivery of oxygen through wet environmentssuch as found on many of themillion patients with chronic wounds in the United States

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Rochal Industries, LLC SBIR Phase I Award, September 2018

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.